share_log

多瑞医药:中信证券股份有限公司关于西藏多瑞医药股份有限公司2023年度跟踪报告

Tibet Duo Rui Pharmaceutical: CITIC Securities Co., Ltd.'s 2023 follow-up report on Tibet Dorui Pharmaceutical Co., Ltd.

Sensex a share ·  May 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more